ArticleOncotarget2017

CM363, a novel naphthoquinone derivative which acts as multikinase modulator and overcomes imatinib resistance in chronic myelogenous leukemia.

Borja Guerra et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.